SCHEDULE 13G: FMR LLC and Abigail P. Johnson Disclose 8.1% Passive Stake in Elanco Animal Health Inc.

FMR LLC and its affiliate Abigail P. Johnson have filed a Schedule 13G, reporting a passive beneficial ownership of 8.1% in Elanco Animal Health Inc. as of December 31, 2024.

Summary

• FMR LLC and Abigail P. Johnson collectively beneficially own 40,232,326.61 shares of Elanco Animal Health Inc. common stock.
• This ownership represents 8.1% of the total outstanding common stock of Elanco Animal Health Inc.
• FMR LLC holds sole voting power over 36,492,081.38 shares and sole dispositive power over 40,232,326.61 shares.
• Abigail P. Johnson, as a Director, Chairman, and CEO of FMR LLC, is also deemed to beneficially own the same aggregate amount of shares, with sole dispositive power over 40,232,326.61 shares.
• The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Elanco Animal Health Inc.
• Several FMR LLC subsidiaries, including FIAM LLC, Fidelity Diversifying Solutions LLC, Fidelity Institutional Asset Management Trust Company, Fidelity Management & Research Company LLC, Fidelity Management Trust Company, and Strategic Advisers LLC, are identified as entities that beneficially own shares.

Sentiment

Score: 5

Explanation: The document is a routine beneficial ownership disclosure (Schedule 13G) indicating a passive stake. It contains factual information about ownership percentages and does not provide performance results, strategic updates, or other information that would typically drive strong positive or negative sentiment.

Positives

• The disclosure of a significant 8.1% stake by a major institutional investor like FMR LLC can be viewed as a vote of confidence in Elanco Animal Health Inc.'s long-term prospects.
• The passive nature of the investment, as certified by FMR LLC, suggests stability and a lack of immediate activist intent, which can be reassuring to current management and shareholders.

Risks

• While the filing states the ownership is passive, a large institutional stake always carries the potential for future shifts in investment strategy, which could include a change to an active role or divestment, though not indicated in this filing.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Elanco Animal Health Inc.'s future financial performance or strategic direction.

Industry Context

This filing reflects a routine disclosure by a major asset management firm, FMR LLC (Fidelity), of its significant passive investment in Elanco Animal Health Inc., a prominent company in the animal health sector. Such institutional holdings are common and indicate a large fund's position in a publicly traded company within its investment portfolio.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive stake by a major institutional investor like FMR LLC may be viewed positively, signaling institutional confidence in the company.

Key Dates

Keywords

Elanco Animal Health Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Animal Health, Passive Investment